Open Journal of Blood Diseases

Volume 8, Issue 1 (March 2018)

ISSN Print: 2164-3180   ISSN Online: 2164-3199

Google-based Impact Factor: 0.56  Citations  

Severe Hepatic Sinusoidal Obstruction Syndrome during the Induction Chemotherapy of Burkitt’s Lymphoma

HTML  XML Download Download as PDF (Size: 407KB)  PP. 10-16  
DOI: 10.4236/ojbd.2018.81002    882 Downloads   2,000 Views  

ABSTRACT

The Hepatic sinusoidal obstruction syndrome (HSOS), also known as veno-occlusive disease (VOD), is a well-known complication of haematopoietic stem cell transplantation, of the treatment of Wilms tumor and rhabdomyosarcoma and maintenance therapy of acute lymphoblastic leukemias. Its occurrence is rare in other cancers of the child. We report the observation of a 7-year-old girl with Burkitt’s lymphoma who developed a severe HSOS during her second induction treatment with dexamethasone, cisplatin, cytosine arabinoside. The evolution was fatal. This observation shows that the diagnosis of HSOS should not be excluded in the absence of the risk factors usually described.

Share and Cite:

Couitchere, L. , Atiméré, Y. , Koné, D. and Lagou, D. (2018) Severe Hepatic Sinusoidal Obstruction Syndrome during the Induction Chemotherapy of Burkitt’s Lymphoma. Open Journal of Blood Diseases, 8, 10-16. doi: 10.4236/ojbd.2018.81002.

Cited by

No relevant information.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.